
Opinion|Videos|January 27, 2025
Improving Outcomes Through Patient Education and Addressing Unmet Needs
Panelists discuss how comprehensive patient education about tardive dyskinesia risk factors, early warning signs, and available treatments is crucial for improving outcomes, while highlighting remaining unmet needs including better screening tools, enhanced provider training, expanded access to VMAT2 inhibitors, and more research into prevention strategies and novel therapeutic approaches.
Advertisement
Episodes in this series

Video series above is prompted by the following:
- What role does patient education and awareness play in improving outcomes for those at risk for or living with TD?
- What unmet needs remain in the care of patients with TD, and how can further research or collaboration address these gaps?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
PBM Reform Within 2026 Appropriations Bill Signed Into Law
2
Most Favored Nation Drug Pricing: Analysis and Implications
3
From CAR T to Gene Therapy, Pharmacists Prepare for What’s Next at the 2026 Tandem Meeting
4
Q&A: First-in-Class NSD2 Inhibitor KTX-1001 Shows Promise in High-Risk Multiple Myeloma
5


























